71 results found in news
news
CareAcross content
CareAcross
Posted about 5 years ago
New Crizotinib side-effect: reduced measures of kidney function during treatment
A University of Colorado Cancer Center study published today in the journal Cancer shows that using crizotinib to treat ALK positive non-small cell lung cancer (NSCLC) appears to reduce kidney function when assessed by one of the most commonly used clinical methods. Whether this reflects a true effect of crizotinib on kidney function, or only on the accuracy of this particular method for assessing it is a topic of ongoing study.
Read full article